Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 25712055)

Published in Cancer Prev Res (Phila) on February 23, 2015

Authors

Shusuke Toden1, Yoshinaga Okugawa1, Constanze Buhrmann2, Durgha Nattamai3, Esperanza Anguiano3, Nicole Baldwin3, Mehdi Shakibaei2, C Richard Boland1, Ajay Goel4

Author Affiliations

1: Center for Gastrointestinal Cancer Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Charles A Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas.
2: Institute of Anatomy, Ludwig-Maximilian University, Munich, Germany.
3: Baylor Institute for Immunology Research, Baylor Research Institute, Dallas, Texas.
4: Center for Gastrointestinal Cancer Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Charles A Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas. ajay.goel@baylorhealth.edu.

Associated clinical trials:

A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | NCT01829971

Articles cited by this

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87

Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57

MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29

A genetic model for colorectal tumorigenesis. Cell (1990) 44.37

p53 mutations in human cancers. Science (1991) 31.96

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell (1993) 20.72

Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res (2010) 12.96

Bioavailability of curcumin: problems and promises. Mol Pharm (2007) 8.72

The first 30 years of p53: growing ever more complex. Nat Rev Cancer (2009) 8.00

FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer (2008) 7.93

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med (2012) 7.47

The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res (2007) 3.40

MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer (2012) 2.78

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res (2010) 2.50

Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med (2013) 2.33

Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res (1995) 1.96

Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem (2005) 1.76

Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. J Biol Chem (2010) 1.71

Tumor suppressor functions of FBW7 in cancer development and progression. FEBS Lett (2012) 1.64

Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review. J Biochem Mol Toxicol (2011) 1.52

Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat (2014) 1.50

miR-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov (2012) 1.49

Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res (2009) 1.36

Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene (2012) 1.35

A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res (2012) 1.34

Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Cancer Res (2000) 1.34

Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One (2012) 1.26

Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment. Arthritis Res Ther (2010) 1.23

Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. Cancer Prev Res (Phila) (2011) 1.21

Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis (2002) 1.20

Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis (1993) 1.20

Diet and cancer: one view at the start of the millennium. Cancer Epidemiol Biomarkers Prev (2001) 1.13

Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br J Cancer (1999) 1.12

Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells. Cancer Res (2008) 1.11

Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis (1992) 1.10

Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways. PLoS One (2013) 1.10

Curcumin synergizes with resveratrol to inhibit colon cancer. Nutr Cancer (2009) 1.09

Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol (2006) 1.06

Inhibition of chondrogenesis by integrin antibody in vitro. Exp Cell Res (1998) 1.04

Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. BMC Cancer (2012) 1.04

The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo. PLoS One (2013) 1.03

Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis (1996) 1.01

miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. Mol Oncol (2014) 0.98

JC virus mediates invasion and migration in colorectal metastasis. PLoS One (2009) 0.97

Combination of curcumin and green tea catechins prevents dimethylhydrazine-induced colon carcinogenesis. Food Chem Toxicol (2009) 0.96

Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers. Int J Cancer (2011) 0.95

Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells. Curr Eye Res (2012) 0.92

Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression. Int J Cancer (2011) 0.89

Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res (2013) 0.88

Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family. Carcinogenesis (2012) 0.88

Regulating miRNA by natural agents as a new strategy for cancer treatment. Curr Drug Targets (2013) 0.87

The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis. Mol Nutr Food Res (2013) 0.87

N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) triggers MSH2 and Cdt2 protein-dependent degradation of the cell cycle and mismatch repair (MMR) inhibitor protein p21Waf1/Cip1. J Biol Chem (2011) 0.86

Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis. Cancer Prev Res (Phila) (2013) 0.84

Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Med (2004) 0.80